Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole

By Kantarcioğlu A. Serda   Boekhout Teun   Yucel Ayhan   Altas Kemal  

Medical Mycology, Vol. 47, Iss. 2, 2008-07 ,pp. : 169-176

Informa Healthcare

Access to resources Recommend Favorite

Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex

By Trilles Luciana   Meyer Wieland   Wanke Bodo   Guarro Josep   Lazéra Marcia  

Medical Mycology, Vol. 50, Iss. 3, 2012-04 ,pp. : 328-332

Informa Healthcare

Access to resources Recommend Favorite

Analysis of HLA association in susceptibility to infection with Cryptococcus neoformans var. gattii in a Papua New Guinean population

By van Dam M.G.   Seaton R.A.   Hamilton A.J.  

Medical Mycology, Vol. 36, Iss. 3, 1998-06 ,pp. : 185-188

Informa Healthcare

Access to resources Recommend Favorite

Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil

By Andrade-Silva Leonardo   Ferreira-Paim Kennio   Mora Delio Jose   Silva Paulo Roberto Da   Andrade Anderson Assunção   Araujo Natalia Evelyn   Pedrosa André Luiz   Silva-Vergara Mario León  

Medical Mycology, Vol. 51, Iss. 6, 2013-08 ,pp. : 635-640

Informa Healthcare

Access to resources Recommend Favorite

Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study

By Brummer E.   Kamei K.   Miyaji M.  

Medical Mycology, Vol. 36, Iss. 4, 1998-08 ,pp. : 227-233

Informa Healthcare

Access to resources Recommend Favorite